» Authors » Antonio Quintero-Ramos

Antonio Quintero-Ramos

Explore the profile of Antonio Quintero-Ramos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 87
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Korkowski-Uvina K, Gomez-Hernandez N, Quintero-Ramos A, de J Contreras-Rodriguez F, Ortega-Cisneros M
Rev Alerg Mex . 2025 Jan; 71(4):229-233. PMID: 39752264
Objective: To establish the prevalence of bronchiectasis, correlate the IgG IV or SC immunoglobulin dose and serum IgG levels with the total Bhalla score and the severity of bronchiectasis and...
2.
Gutierrez-Zepeda B, Gomez-Del Toro M, Ortiz-Soto D, Becerra-Loaiza D, Quiroz-Bolanos A, Topete A, et al.
Int J Mol Sci . 2024 Sep; 25(18). PMID: 39337657
Breast cancer (BC) is the leading cause of death from tumors in women worldwide, influenced by various factors, including genetics. The T allele of the single nucleotide variant (SNV) rs3025039...
3.
Alves da Quinta D, Rocha D, Retamales J, Giunta D, Artagaveytia N, Velazquez C, et al.
Oncologist . 2024 Aug; 29(12):e1701-e1713. PMID: 39115892
Background: Several guidelines recommend the use of different classifiers to determine the risk of recurrence (ROR) and treatment decisions in patients with HR+HER2- breast cancer. However, data are still lacking...
4.
Garcia-Garduno T, Padilla-Gutierrez J, Aceves-Ramirez M, Parra-Reyna B, Flores-Salinas H, Valdes-Alvarado E, et al.
Sci Rep . 2024 Jun; 14(1):13196. PMID: 38851847
Interleukin-10 (IL-10) is an immunomodulatory cytokine that plays a pivotal role in the pathogenesis of acute coronary syndromes (ACS). Here, we evaluated the role of IL10 promoter variants as markers...
5.
Retamales J, Daneri-Navarro A, Artagaveytia N, Alves da Quinta D, Abdelhay E, Podhajcer O, et al.
JCO Glob Oncol . 2024 May; 10:e2300216. PMID: 38723219
Purpose: Breast cancer mortality rates in Latin America (LA) are higher than those in the United States, possibly because of advanced disease presentation, health care disparities, or unfavorable molecular subtypes....
6.
Nunez-Nunez M, Lona-Reyes J, Lopez-Barragan B, Cruz-Osorio R, Gutierrez-Zepeda B, Quintero-Ramos A, et al.
Front Immunol . 2023 Oct; 14:1194262. PMID: 37795094
The most common causes of congenital neutropenia are mutations in the (Elastase, Neutrophil Expressed) gene (19p13.3), mostly in exon 5 and the distal portion of exon 4, which result in...
7.
Becerra-Loaiza D, Roldan Flores L, Ochoa-Ramirez L, Gutierrez-Zepeda B, Del Toro-Arreola A, Franco-Topete R, et al.
Curr Issues Mol Biol . 2023 Aug; 45(8):6842-6850. PMID: 37623251
HLA-G is a physiology and pathologic immunomodulator detrimentally related to cancer. Its gene is heavily transcriptionally and post-transcriptionally regulated by variants located in regulator regions like 3'UTR, being the most...
8.
Oceguera-Basurto P, Figueroa-Ochoa E, Anguiano-Sevilla L, Sanchez-Ramirez D, Quintero-Ramos A, Del Toro-Arreola A, et al.
Int J Pharm . 2023 Jun; 642:123175. PMID: 37369286
Breast cancer (BC) has surpassed lung cancer as the most diagnosed cancer and, in terms of mortality, is the fifth leading cause with 684,996 new deaths (6.7% of all cancer-related...
9.
Becerra-Loaiza D, Ochoa-Ramirez L, Velarde-Felix J, Sanchez-Zazueta J, Quintero-Ramos A
Postepy Dermatol Alergol . 2023 Jun; 40(2):246-252. PMID: 37312918
Introduction: The HLA-G molecule functions as a critical immunomodulatory checkpoint, its expression is significantly associated with pathological processes that may be responsible in part for autoimmune conditions such as non-segmental...
10.
Llera A, Abdelhay E, Artagaveytia N, Daneri-Navarro A, Muller B, Velazquez C, et al.
Front Oncol . 2022 Apr; 12:835626. PMID: 35433488
Purposes: Most molecular-based published studies on breast cancer do not adequately represent the unique and diverse genetic admixture of the Latin American population. Searching for similarities and differences in molecular...